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Background: Chromosome rearrangements are frequently involved in the
generation of hematopoietic tumors. One type of T-cell leukemia, T-cell
prolymphocytic leukemia, is consistently associated with chromosome
rearrangements characterized by the juxtaposition of the TCRA locus on
chromosome 14q11 and either the TCL1 gene on 14q32.1 or the MTCP1
gene on Xq28. The TCL1 gene is preferentially expressed in cells of early
lymphoid lineage; its product is a 14 kDa protein (p14TCL1), expressed in the
cytoplasm. p14TCL1 has strong sequence similarity with one product of the
MTCP1 gene, p13MTCP1 (41% identical and 61% similar). The functions of the
TCL1 and MTCP1 genes are not known yet. They have no sequence similarity
to any other published sequence, including those of well-documented
oncogene families responsible for leukemia. In order to gain a more fundamental
insight into the role of this particular class of oncogenes, we have determined
the three-dimensional structure of p14TCL1.
Results:  The crystal structure of p14TCL1 has been determined at 2.5 Å
resolution. The structure was solved by molecular replacement using the
solution structure of p13MTCP1, revealing p14TCL1 to be an all-β protein
consisting of an eight-stranded antiparallel β barrel with a novel topology. The
barrel consists of two four-stranded β-meander motifs, related by a twofold axis
and connected by a long loop. This internal pseudo-twofold symmetry was not
expected on basis of the sequence alone, but structure-based sequence
analysis of the two motifs shows that they are related. The structures of
p13MTCP1 and p14TCL1 are very similar, diverging only in regions that are either
flexible and/or involved in crystal packing. p14TCL1 forms a tight crystallographic
dimer, probably corresponding to the 28 kDa species identified in solution by
gel filtration experiments. 
Conclusions:  Structural similarities between p14TCL1and p13MTCP1 suggest
that their (unknown) function may be analogous. This is confirmed by the fact
that these proteins are implicated in analogous diseases. Their structure does
not show similarity to other oncoproteins of known structure, confirming their
classification as a novel class of oncoproteins.
Introduction
Many somatically acquired aberrant genetic changes are
responsible for cancer. These changes can be classified as
deletions, translocations and inversions [1,2]. Many malig-
nancies of the hematopoietic lineage exhibit non-random
chromosomal translocations. The paradigm of chromoso-
mal rearrangement associated with lymphoid malignancies
has been described initially in the B-cell disease named
Burkitt’s lymphoma. This neoplasm is associated with
chromosomal translocations that juxtapose the cellular
proto-oncogene c-myc, from band 8q24, and the
immunoglobulin gene locus IGH (on chromosome
14) — t(8;14) — or less commonly the IGL or IJK loci (on
chromosomes 22 and 2, respectively) [3]. The conse-
quences of these rearrangements are perturbations of the
transcriptional regulation of c-myc , leading to modifica-
tions of the cell growth and differentiation properties.
Thereafter, many other lymphoid neoplasms of B- and T-
cell origin have been associated with translocations within
immunoglobulin gene loci and T-cell receptor gene loci,
respectively. The molecular characterization of these
translocations allowed the identification of several cellular
genes, such as BTG, LYL1, TAL1/SCL, TAL2, HOX11,
BCL6/Laz3, BCL1/CLND1, TAN1, LMO1 and LMO2, found
to be important for the malignant transformation of lym-
phoid cells [2].
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Recurrent chromosomal rearrangements, such as trans-
location t(14;14)(q11;q32.1), inversion inv(14)(q11q32) or
translocation t(7;14)(q35;q32.1), implicated both the
chromosome region 14q32.1 and a TCR (T-cell receptor)
locus. These chromosomal aberrations are observed in T-
cell neoplasms classified as T-prolymphocytic leukemia (T-
PLL) or T-cell chronic lymphoid leukemias (T-CLL) [4,5]
and in T-cell leukemic and pre-leukemic diseases, arising
in patients with the immunodeficiency syndrome ataxia
telangiectasia (AT) (reviewed in [6,7]). Given the phys-
iopathologic model previously described in Burkitt’s lym-
phoma, the presence of an oncogene has been postulated in
the 14q32.1 region by Croce et al. [8]. Although several
rearrangements involving this region have been character-
ized at the molecular level [9–14], for a long time it was dif-
ficult to define the affected gene. This was due to the
complexity of the chromosomal rearrangements, including
inversions, translocations and sometimes duplications, and
because of the large size of the implicated region. Virgilio et
al. [15] first defined the organization and the physical
linkage of the breakpoints within the 14q32.1 region. The
placement of the translocation breakpoints on the long-
range genomic map showed that the TCL1 (T-cell
leukemia) locus is a large region (~350 kb) and suggests that
the activation of the TCL1 gene can occur from a distance of
many kb. The TCL1 gene was finally found by using exon
trapping and Northern blot analysis. It codes for a 1.3 kb
transcript and is expressed in a restricted subset of lym-
phoid cells; this gene is and strongly expressed in leukemic
cells carrying a t(14;14)(q11;q32) chromosome translocation
or a inv(14)(q11;q32) inversion [16]. cDNA sequencing of
the TCLI gene revealed an open reading frame that codes
for a 114 amino acid protein named p14TCL1, preferentially
expressed early in T- and B-lymphocyte differentiation,
which was initially localized in the microsomal fraction [17].
Experiments run in our laboratory suggested a predominant
localization of both p13MTCP1 (see below) and p14TCL1 in
the cytosol fraction (M-HS, unpublished data). Analysis of
the expression of TCL1 in different cell lines suggests that it
may be linked to immunoglobulin and TCR gene rearrange-
ment and expression.
p14TCL1 has considerable sequence homology with
another protein, encoded for by the gene MTCP1 that is
situated on the human X chromosome and also involved in
chromosomal translocations in T-cell proliferative diseases
[18]. This gene codes for two entirely different proteins
p13MTCP1 and the p8MTCP1 [19,20]; p13MTCP1 is overex-
pressed in the T-cell malignancies associated with t(X;14)
translocations [19,21]. This 107 amino acid protein shows
strong sequence identity with p14TCL1 (41% identity and
61% similarity); however, p13MTCP1 and p14TCL1 have no
sequence similarity with any other known gene sequence. 
The function of both proteins is unknown at this time,
but transgenic and gene knock-out experiments are
underway to assess their cellular role. In order to gain
insight into the functions and oncogenic mechanisms of
these proteins, we report here the three-dimensional
structure of p14TCL1, as elucidated by X-ray crystallo-
graphy at 2.5 Å resolution. The structure of p13MTCP1 was
also determined in our laboratory by high resolution
NMR spectroscopy [22,23].
Results and discussion
Determination and quality of the structure
p14TCL1 was overexpressed as a GST-fusion protein and
purified to sufficient quantities for structure determina-
tion. Mass spectrometric analysis revealed that the over-
expressed protein had the correct mass, taking into
account the extra residues at the N terminus originating
from the expression vector. The protein crystallized near
pH 4.2 without the need for any precipitant. Crystal con-
tacts in the c-direction involve close contacts between
Asp16 and Asp114 of a symmetry-related molecule. The
supposed neutralization of one of these carboxylate groups
could explain the crystallization behaviour of this protein.
The crystals grew as thin plates, which is in accordance
with the packing of the molecules in the crystal (see
below). Heavy atom soaking experiments did not yield
any useful derivatives (see Material and methods), so we
proceeded by molecular replacement using the solution
structure of p13MTCP1 (determined in parallel in our labo-
ratory [22,23]). The solution structure was determined
using non-labelled protein by homonuclear multidimen-
sional techniques and was very well defined in the region
between residues 11–103, corresponding to residues
16–111 in p14TCL1. The root mean square (rms) deviation
of the NMR backbone positions of the structured core for
the 20 best p13MTCP1 structures was 1.07 Å. For the
molecular replacement calculations, we removed certain
regions of the solution structure (p14TCL1 numbering) —
residues 1–15 at the N terminus, residues 54–74 in the
long loop between β strands D and E and residues
110–114 at the C terminus — because these regions were
less well defined than the core of the protein. We found
one solution for the I222 space group that yielded a realis-
tic packing coefficient and slightly higher correlation coef-
ficients between observed and calculated structure factors
than those of the background values. Initial refinement
cycles showed that for this solution Rfree diminished in
contrast to false solutions with similar molecular replace-
ment scores. The refinement of this solution at 2.5 Å went
smoothly and after the first cycle (at 3.0 Å resolution), the
residues in the long loop and most of the missing
sidechains could be readily placed in the residual electron
density maps. 
The refinement statistics are gathered in Table 1. The
model was refined to an R factor of 19.2% (Rfree = 25.9%
for 10% of the reflections never used in the refinement)
and has good stereochemistry with no residues outside the
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allowed regions of the Ramachandran plot. The electron
density is excellent for residues 7–113. The six N-terminal
residues are poorly ordered and no density can be
observed for the C-terminal residue. Figure 1 shows a rep-
resentative part of the 2Fo–Fc electron density map after
final refinement. The final model contains 924 protein
atoms and 50 water molecules.
Description of the overall structure
p14TCL1 is a compact molecule with overall dimensions
40 × 27 × 36 Å. It belongs to the β class of proteins with
50% of its residues arranged into β strands. The structure
of p14TCL1 is a closed antiparallel β barrel, consisting of
eight β strands of variable length (A–H) and an extra
strand at the N terminus (strand 0). The sequence of
p14TCL1 with β strands labelled is shown in Figure 2a.
The barrel consists of two very similar up-and-down four-
stranded β-meander motifs: motif 1, composed of strands
A–D, and motif 2, composed of strands E–H. A long loop
following strand D inverts the second motif by juxtapos-
ing strand E to strand A. The topology diagram is shown
in Figure 2b and a schematic representation of the struc-
ture is seen in Figures 2c and 2d. The structure can also
be considered as a stacking of two perpendicular four-
stranded β sheets that are packed tightly against each
other through a hydrophobic core. Each sheet contains
two β strands from each motif. One sheet is composed of
the shorter strand pairs (A–B and E–F), whereas the other
contains all the longer ones (C–D and G–H). The ends of
the two long β-strand pairs (C–D and G–H) are not
involved in the barrel hydrogen bond pattern and are pro-
truding from the core of the molecule.
Each motif consists of one short (A–B or E–F) and one
long two-stranded β sheet (C–D or G–H), which together
form an L-shape. As can be seen in the ribbon presenta-
tion of the structure (Figure 2c), the two motifs (coloured
green and yellow) are related in the structure by a pseudo-
twofold axis. This pseudo-twofold axis lies in the meridian
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Table 1
Data collection and refinement statistics.
Total number of reflections 60,407
Total number of unique reflections 6870
Redundancy 8.8
Completeness (%) (resolution range 40–2.5 Å) 99.4
Completeness (%) (resolution range 2.6–2.5 Å) 99.9
Mosaicity 0.37
Rmerge (%)* 9.9
Rmerge (%)* (resolution shell 2.6–2.5 Å) 28.8
Number of reflections used in refinement (working set) 6644
Initial R factor (%)† (resolution range 8–2.5 Å) 56.7
Initial Rfree (%)‡ (resolution range 8–2.5 Å) 54.3
Final R factor (%)† (resolution range 8–2.5 Å) 19.2
Final Rfree (%)‡ (resolution range 8–2.5 Å) 25.9
Rms deviation in bond angles (°) 1.29
Rms deviation in bond lengths (Å) 0.006
Average B factor (Å2)/rms value 29.6/16
Number of non-hydrogen protein atoms 924
Number of water molecules 50
*Rmerge = Σ | Ii–Im | /Σ Im, where Ii and Im are the observed intensity
and mean intensity of related reflections. †R = Σ |Fobs–Fcalc|  / Σ Fobs for
the remaining 90% of the data included in the refinement. 
‡Rfree = Σ |Fobs–Fcalc| / Σ Fobs for 10% of data randomly selected and
excluded from the refinement. 
Figure 1
Stereoview of the electron-density map of the
p14TCL1 surface loop (residues 22–26) that
has a different sequence from the p13MTCP1
structure, used in the molecular replacement
procedure. The map is contoured at 1σ level
using (2Fo–Fc) coefficients and phases from
the refined model. Atoms are coloured by
atom type (carbon, yellow; oxygen, red;
nitrogen, blue).
plane of the barrel, crossing through strands D and H, and
A and B. In Figure 3a, we show the superposition of the
two motifs, revealing their excellent match (rms distance
for 38 Cα positions is 1.2 Å). We used this structural
information to investigate if the sequences of the motifs
are related (sequence alignment of the two motifs is
shown in Figure 3b). There is no obvious sequence iden-
tity between the first and the second motif, but a few
crucial residues are at identical positions in the two motifs.
For instance, Trp34 (first residue of strand C) is equiva-
lent to residue 92 (first residue of strand G) and Trp21 in
the first motif corresponds to Tyr79 in the second motif.
The two equivalent tyrosines (26 and 84) make identical
hydrogen bonds in the two motifs: Tyr26 OH hydrogen
bonds to the carbonyl oxygen of Pro73 from the other
motif, and an equivalent H-bond is observed between
Tyr84 and Pro15. We postulate that the structure of
p14TCL1 is build from a repeated motif and that the
p14TCL1 sequence has evolved by gene duplication.
The six N-terminal residues of p14TCL1 are poorly ordered.
Residues 1–11 form an extension from the core of the mol-
ecule and are involved in crystal packing (see below).
Residues 8–10 make mainchain hydrogen bonds with
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The sequence and structure of p14TCL1. (a) Sequence alignment and
secondary structure assignment of p14TCL1 (top row) and p13MTCP1
(bottom row). Conserved residues are boxed in blue. The first strand
is not really part of the barrel and is therefore labeled 0. (b) Topology
diagram of the p14TCL1 barrel structure. The two repeated motifs are
coloured green (strands A–D) and yellow (strands E–H). (c,d) Two
ribbon representations of the p14TCL1 crystal structure as generated
by the programs MOLSCRIPT and Raster3D [35,36], with the same
colouring of the motifs as in (b). Two different orientations are
shown: one looking sideways (c) onto the barrel and one looking
from the top (d). 
strand G just before a bend in the chain and the start of
strand A. We call this short stretch strand 0, because it does
not really belong to the barrel structure. The conformation
of strand 0 in the crystal structure is probably influenced
by packing. The corresponding region in the p13MTCP1
NMR solution structure is not very well defined.
The strands within each motif are connected by short
turns and the two motifs are separated by the long loop
(residues 54–74). Four turns (between strands A–B, B–C,
E–F and F–G) are type I and the turn between strands
G–H is type I′. All of the turns are composed of four
residues, with the exception of turn AB, which contains an
extra residue from a bulge (Trp21) at the exit of strand A,
and the non-canonical CD turn, which contains a fifth
residue (Gln46) from a bulge at the entry of strand D. The
connection between the two motifs is made by the long
loop (from Glu54 to Ile74) joining strand D and E. This
loop forms a cap over the first motif and its conformation
is stabilized by two mainchain hydrogen bonds between
the loop and residues from the barrel and by hydrophobic
packing of sidechains from the loop (Val56, Leu58, Pro61
and Ile67) and from the outside of the first barrel motif
(Trp21, Val25 and Leu35). The loop contains one helical
turn (Pro64–Gly68).
Crystal packing
p14TCL1 packs in the crystal in layers. The packing is tight
in the ab-plane but very loose in the c-direction. This
packing explains why the crystals grow as thin plates and
also explains the anisotropic diffraction behaviour,
observed with some of the crystals. The connection
between successive layers in the c-direction relies entirely
on the N-terminal residues (1–11), which extend from the
core of the protein to make crystal contacts with a mole-
cule from the neighbouring layer (see Figure 4a). The
N-terminal extensions cross each other in an antiparallel
manner and form a suspender-like connection. The inter-
actions between the two N-terminal stretches are hydro-
phobic, involving the sidechains of residues Met1, Ala4,
Pro5, Thr6, Leu7, Ala10, Tyr96 and Ile98.
In the ab plane, the molecules form tight crystallographic
dimers. The principal dimer contact is conferred by the
antiparallel β-sheet packing of the C-terminal ends
(residues 37–41) of the C-strands of two symmetry-related
molecules (see Figure 4b). This contact results in a con-
tinuous eight-stranded β sheet formed by the strands C,
D, G and H from each monomer. Gel filtration experi-
ments suggest that, at least under purification conditions
(relatively high protein concentration compare to the
physiological concentration), p14TCL1 elutes from the
column as a dimer. The mass spectrum also showed a
contaminant peak with exactly twice the molecular weight
of the monomer. We therefore cannot exclude that
p14TCL1 forms a dimer in solution. The total surface area
buried by crystal contacts is about 1800 Å2, which is in the
range found for protein–protein complexes. The dimer is
stabilized by the above mentioned antiparallel β-sheet
formation and by hydrophobic contacts involving Pro36,
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Comparison of the two structural motifs comprising the core of the
p14TCL1 structure. (a) Backbone superposition of the repeated
structural motif of p14TCL1. Same colour coding as in Figure 2b: green
(strands A–D) and yellow (strands E–H). The sidechains of the
conserved residues in the two motifs are also shown. (b) Sequence
alignment based on the structural superposition of the two motifs;
conserved residues are boxed in blue.
Ile39, Ile41 and Leu47. Our NMR experiments, however,
gave no similar indication for dimer formation of p13MTCP1
in solution. The sequence alignment of the two proteins
shows that p13MTCP1 has some deletions in the regions
that participate in dimer formation of p14TCL1. Compari-
son of both structures reveals a different conformation at
the exit of strand C between these proteins, which could
be  the origin of a different quaternary structure.
Comparison with the solution structure of p13MTCP1
p14TCL1 has considerable sequence identity with
p13MTCP1 (41% identical and 61% similar), the structure of
which has also been determined in our laboratory by high
resolution NMR spectroscopy. The success of the molecu-
lar replacement calculations used to determine the
structure of p14TCL1 confirmed the presumption that the
two proteins have the same overall structure. p14TCL1 has
five extra residues at the N-terminal extension compared
to p13MTCP1. As mentioned above, the conformation of
these residues is dictated by crystal contacts. No long dis-
tance NOEs are observed for the ten N-terminal residues
in the structure of p13MTCP1, resulting in a badly defined
region for this part of the molecule. There is also some
divergence for the C-terminal region between the crystal
and solution structures.
A superposition of the backbone structures of p13MTCP1
and p14TCL1 is represented in Figure 5. The residues that
form the secondary structure elements superpose per-
fectly. The rms distance for 75 Cα positions, comprising
practically all the residues from the β sheets, is 1.1 Å.
Some divergence between the two structures is observed
in a few turns and in the long loop. p14TCL1 has two inser-
tions compared to p13MTCP1: one in strand C and one in
the turn between strands C and D. These insertions
induce slight differences in the conformation of the turn.
Apart from the terminal segments, the biggest differences
between the two structures are observed in the long loop.
This is also the region where both protein sequences
diverge most, and in the solution structure, it is less well
defined than the core of the barrel [22,23]. The crystal
structure of p14TCL1 has good electron density for this
region, but its conformation could be influenced by some
crystal contacts. The orientation of this loop, relative to
the barrel, differs between the two structures from residue
Leu58 onwards. The crystal structure also contains one
152 Structure 1998, Vol 6 No 2
Figure 4
Stereoview of the Cα backbone of p14TCL1,
showing the packing in the crystals.
(a) Interactions through the N-terminal
extensions in the c-direction between two
successive layers. (b) Extended β-sheet
formation between crystal symmetry-related
molecules in the same layer.
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helical turn (Pro64–Gly68) that was not observed in the
solution structure. 
Comparison to other structures and indications for
functionality
p14TCL1 and p13MTCP1 have no sequence similarity to any
other known protein. Although the structure belongs to
the widely spread family of β-barrel proteins, it has, to our
knowledge, an original topology. Geometrically, it can be
classified according to the criteria of Murzin et al. into the
barrel family, the proteins in which contain eight strands
and have a shear number of ten [24,25]. It is therefore
related to the β barrels found in beef liver catalase, strep-
tavidin and cyclophilin A (three functionally unrelated
proteins).
The interior of the barrel is tightly packed and contains
the majority of hydrophobic residues. In the p14TCL1
crystal and p13MTCP1 solution structures, there is no space
in the core for binding of a ligand, as is observed in the
related barrel protein family of the lipocalins [26]. The
charged residues are all on the surface of the molecule,
concentrated in the turn and loop regions. We calculated
the electrostatic potential surface of the molecule using
GRASP ([27]; results not shown). A negatively charged
patch is observed in the region around the connection
between strand 0 and strand A, due to a spatial concentra-
tion of carboxylic acid sidechains (Glu9, Asp13, Asp16,
and Glu29).
Many oncogenes interfere with the regulation of cell divi-
sion and apoptosis. Some of these are nucleic acid binding
proteins, whereas others are involved in cell signalling.
The sequences of p14TCL1 and p13MTCP1 do not allow
them to be classified among any of the known oncogene
families and the three-dimensional structure does not yet
give indications of its function. As p14TCL1 does not seem
to have any documented catalytic activity and its tertiary
structure does not provide evidence for a catalytic site,
p14TCL1 probably acts through interaction with other
molecules. The compactness of the barrel core suggests
that this interaction involves the turns, the loop or the
β-sheet extensions of the core of the protein. The
considerable sequence similarity and almost identical
three-dimensional structure between p14TCL1 and
p13MTCP1 suggest that these two proteins exert similar
functions. This is in accordance with the fact that both
proteins are involved in similar diseases. Regions of high
homology between the two proteins are mainly found in
the barrel. 
Biological experiments (e.g. yeast double hybrids) are
running in our laboratory to gain more insight into the
function of these proteins. An important step will be to
find the molecular interaction partner of p14TCL1. The
three-dimensional structure will at that moment be
extremely useful for the design of further experiments.
Biological implications
Many malignancies are the result of abnormal chromo-
somal reorganizations that perturb the expression and
function of important genes. Chromosomal transloca-
tions and/or inversions are often involved in leukemo-
lymphomagenesis, causing changes to the expression
level and sometimes the structure of the proteins
encoded by genes situated near the chromosomal
breakpoint. Oncogenesis appears to occur by two dif-
ferent mechanisms: deregulated expression of normal
proteins or creation of fusion proteins with aberrant
properties [2].
Two different break-association points involved in inver-
sions of chromosome 14 — inv(14) — were identified:
14q11,  in the TCRA locus, and a second type of 14q32
breakpoint was located centromeric to the IGH gene at
14q32.1, corresponding to the TCL1 gene. The sequence
of this gene is homologous to the MTCP1 gene. This
latter gene is involved in rare translocations associated
with mature T-cell proliferations in normal individuals
or in patients suffering from ataxia telangiectasia; this
translocation involves the TCRA/D locus and a common
breakpoint on Xq28.
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Figure 5
Cα backbone superposition of the p14TCL1
crystal (thick lines) and p13MTCP1 solution
(thin lines) structures.
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Structure
Neither the in vivo nor the in vitro function of the two
proteins coded by TCL1 and MTCP1 is known. Their
sequence does not show any homology to other known
protein sequences. We determined earlier the solution
structure of p13MTCP1 [22,23] and here we present the
crystal structure of p14TCL1. As expected from their
analogous sequences, the two proteins have very
similar three-dimensional structures. p14TCL1 and
p13MTCP1 are both all-β proteins, having an eight-
stranded barrel structure with novel topology. The
structure of p14TCL1 consists of two four-stranded
β-meander motifs that can be perfectly superposed. By
virtue of the 3D-structure, an internal sequence homo-
logy between the two repeated motifs was discovered,
suggesting that the protein has probably evolved by
gene duplication.
The 3D-structure does not yet give hints on the possible
functional role of these proteins, but upon discovery of
its molecular interaction partner, it will form a firm basis
for the design of experiments. The structure shows that
this oncoprotein is clearly different from other known
proteins involved in leukemia, such as BCL2 (whose
overexpression prevents apoptosis) or TAL1 — a bHLH
DNA-binding protein associated with T-cell acute
leukemia. Furthermore, the compact nature of the
barrel core excludes any solute binding, as observed in
the lipid-binding barrel protein family. p14TCL1 and
p13MTCP1 therefore probably interact with their partners
through the loops and or β-strand extensions. 
Materials and methods
Cloning, protein expression and purification
The cDNA for p14TCL1 was obtained and subcloned into the
BamHI–EcoRI site of the pGEX-2T vector (Pharmacia) for overexpres-
sion in E. coli. BL21DE3 E. coli was transformed with recombinant
plasmid and grown for 8 hours at 37°C in a 4 l fermentor. Expression
was induced for 3 h by addition of 1.0 mM IPTG. Cells were harvested
by centrifugation and stored at –80°C. After thawing, 30 g of cells
were suspended in 300 ml of 100 mM Tris-HCl (pH 7.5), 100 mM
NaCl, 5 mM EDTA, 5 mM DTT, 5 mM Benzamidine and 0.5 mg/ml
lysozyme. After sonication, the suspension was centrifuged and PEI
added (0.2% final concentration) to precipitate nucleic acids. The
supernatant was then applied onto a 20 ml glutathione–Sepharose-6B
(Pharmacia) column equilibrated with 50 mM Tris-HCl (pH 7.5), 50 mM
NaCl, 5 mM DTT. GST cleavage was carried out on the column-bound
fusion protein with 30 U/ml of bovine thrombin (SIGMA, St Louis) at
room temperature. The cleavage reaction was slow and incomplete,
but the yield was sufficient to allow further purification. The supernatant
was then brought onto a Q HiLoad Sepharose column (Pharmacia,
Uppsala) equilibrated against 50 mM Tris-HCl (pH 7.5), 50 mM NaCl,
5 mM DTT. The protein was eluted with a 0.05 M to 2.0 M linear NaCl
gradient. Pooled fractions were then concentrated on an Amicon dialy-
sis cell with a Diaflo YM3 ultrafiltration membrane and subsequently
applied to a final gel filtration step (Sephadex HR 100, Pharmacia,
equilibrated against 10 mM Tris-HCl, pH 7.5, 300 mM NaCl, 5 mM
DTT). The pooled fractions were finally concentrated to 6 mg/ml. The
purity of the protein was checked by SDS–PAGE. Purified protein was
analysed by mass spectroscopy that yielded a molecular mass (13,676
dalton) compatible with the value calculated from the sequence
(13,675 dalton). The integrity of the N terminus was confirmed by
N-terminal amino acid sequencing.
Crystallization, data collection and processing
p14TCL1 was crystallized using the sparse matrix crystallization screen
(Hampton Research, California) with the hanging drop vapour diffusion
method. Crystals were obtained under various conditions, but refining
these conditions revealed that the determining factor for obtaining
them is pH. In fact crystals are obtained whenever the pH approaches
a value of 4.2, independently of the presence of precipitant. Crystals
appear after a few days and grow steadily over a few weeks, very often
from precipitated protein. These crystals invariably grow as clusters of
thin plates (biggest size 300 µm × 400 µm × 30 µm) and all attempts to
improve upon this failed. Best crystals were obtained at room tempera-
ture by mixing 1 µl of protein (0.4 mM in 10 mM Tris-HCl pH 7.5) with
1 µl of 50 mM Na Acetate or 50 mM Succinate, pH 4.2. The crystals
belonged to the spacegroup I222 or I212121 (a = 38.2 Å, b = 82.8 Å
and c = 117.7 Å). Single crystals have been cut out of the clusters and
were mounted for diffraction analysis. Crystal characterization and deriv-
ative search was carried out on a RIGAKU rotating anode X-ray gener-
ator equipped with a MAR-Research imaging plate detector. Spots
were integrated using DENZO and SCALEPACK [28].
Higher resolution data were collected on the DW32 wigler synchrotron
beamline (LURE, France) at a wavelength of 0.99Å using a MAR-
Research imaging plate detector. A fairly complete data set to 2.5 Å
resolution was collected at room temperature by 1.5° oscillation
images (120 s exposure time). The Rmerge value was 9.9% (29% in the
last resolution shell). A summary of data collection statistics can be
found in Table 1.
Phasing
Heavy atom soaking experiments did not yield any useful derivatives,
despite the presence of a single cysteine. We therefore introduced
extra cysteines by site-directed mutagenesis, but of the five mutants
tried only the S90C mutant crystallized. Soaking of these mutant crys-
tals in 100 mM HgAc did not result in any interpretable Harker peaks.
We also prepared a selenomethionyl protein that purified and crystal-
lized readily, however, crystals remained too small for data collection. 
The structure was finally solved by molecular replacement using the
AMORE package [29]. As a model, we used the NMR structure of the
homologous protein p13MTCP1 [22,23]. Non-identical residues between
the sequences were replaced by alanines and residues at the N and C
termini, for which no long-range NOEs were observed, as well as a
long loop between residues 54 and 74 were removed. Data between
8.0 and 3.5 Å were used in the molecular replacement procedure. The
rotation function failed to give a clear solution. Translation function cal-
culations on about 100 rotation function peaks gave one solution
which was clearly contrasted from the background and indicated the
correct spacegroup as I222 (R = 52% and correlation factor = 22%;
R = 55.2% and correlation factor = 18% for the highest noise peak).
This solution was verified by a realistic crystal packing.
Rigid-body refinement and a first cycle of simulated annealing refine-
ment (X-PLOR [30]), using data between 8.0 and 3.0 Å, brought the R
factor down to 46%. Inspection of 2Fo–Fc maps revealed clearly elec-
tron density for most of the missing residues and sidechains. The
model was further completed using the graphics programme TURBO-
FRODO [31]. The model was refined and completed by successive
rounds of model building and simulated annealing (all data between
8.0 and 2.5 Å) [32]. The progression of the refinement was evaluated
by the Rfree value for 10% of the reflections not included in the refine-
ment [33]. The final model has an R factor of 19.2% (Rfree = 25.9%)
and has good stereochemistry (Table 1). The model contains 924 non-
H protein atoms and 50 water molecules. A Ramachandran plot analy-
sis with the progam PROCHECK revealed all residues in the most
favoured (89%) or additional allowed (11%) regions [34].
Accession numbers
The atomic coordinates for the structure of p14TCL1 have been
deposited with the PDB (accession code 1JSG).
154 Structure 1998, Vol 6 No 2
Acknowledgements
We thank the staff of the DW32 beamline at LURE (Orsay) and the D2AM
beamline at ESRF (Grenoble). We thank particularly Roger Fourme and
Xavier Perez for help at DW32 and Eric Fanchon and Richard Kahn for assi-
tance on D2AM. We are very grateful to Marie-Paule Strub for technical
assitance and to Christian Roumestand for critical reading of the manu-
script. This work was supported by the Association pour la Recherche sur
le Cancer. 
References
1. Croce, C.M. (1987). Role of chromosome translocations in human
neoplasia. Cell 49, 155-156.
2. Rabbitts, T. (1994). Chromosomal translocations in human cancer.
Nature 372,143-149.
3. Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. &
Croce, C. (1982). Human c-myc oncogene is located on the region of
chromosome 8 that is translocated in Burkitt lymphoma cells. Proc.
Natl. Acad. Sci. USA 79, 7824-7827.
4. Hecht, F., Morgan, R., Hecht, B.K. & Smith, S.D. (1984). Common
region on chromosome 14 in T-cell leukemia and lymphoma. Science
226, 1445-1447.
5. Zech, L., et al., & Smith, C.I.E. (1984). Inversion of chromosome 14
marks human T-cell chronic lymphocytic leukemia. Nature 308, 858-
862.
6. Taylor, A.M.R., Metcalfe, J.A., Thick, J. & Mak, Y.F. (1996). Leukemia
and lymphoma in ataxia telangiectasia. Blood 87, 423-438
7. Stern, M.H. (1993). Clonal T-cell proliferations in ataxia telangiectasia.
In The Causes and Consequences of Chromosomal Aberrations.
(Kirsch, I.R., ed.) pp. 165-176, CRC Press, Boca Raton.
8. Croce, C.M., et al., & Rovera, G. (1985). Gene for alpha-chain of
human T-cell receptor: location on chromosome 14 region involved in
T-cell neoplasms. Science 227, 1044-1047.
9. Baer, R., et al., & Rabbitts, T.H. (1987). The breakpoint of an inversion
of chromosome 14 in a T-cell leukemia: sequences downstream of the
immunoglobulin heavy chain locus are implicated in tumorigenesis.
Proc. Natl. Acad. Sci. USA 84, 9069- 9073.
10. Bertness, V.L., et al., & Kirsch, I.R. (1990). Characterization of the
breakpoint of a t(14;14)(q11.2;q32) from the leukemic cells of a
patient with T-cell acute lymphoblastic leukemia. Cancer Genet.
Cytogenet. 44, 47-54.
11. Mengle-Gaw, L., et al., & Rabbitts, T.H. (1987). Human T-cell tumors
containing chromosome 14 inversion or translocation with breakpoints
proximal immunoglobulin joining regions at 14q32.1. EMBO J. 6,
2273-2280.
12. Mengle-Gaw, L., Albertson, D.G., Sherrington, P.D. & Rabbitts, T.H.
(1988) Analysis of a T-cell tumor-specific breakpoint cluster at
chromosome 14q32. Proc. Natl. Acad. Sci. USA 85, 9171-9175
13. Russo, G., et al., & Croce, C.M. (1988). Molecular analysis of a
t(7;14)(q35;q32) chromosome translocation in a T cell leukemia of a
patient with ataxia telangiectasia. Cell 53,137-144.
14. Russo, G., et al., & Croce, C. M. (1989) Molecular analysis of a
t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia
patient. Proc. Natl. Acad. Sci. USA 86, 602-606.
15. Virgilio, L., et al., & Russo, G. (1993) Chromosome walking on the
TCL1 locus involved in T-cell neoplasia. Proc. Natl. Acad. Sci. USA
90, 9275-9279.
16. Virgilio, L., et al., & Russo, G. (1994) Identification of the TCL1 gene
involved in T-cell malignancies. Proc. Natl. Acad. Sci. USA 91,
12530-12534.
17. Fu, T.-B., Virgilio, L., Narducci, M.G., Facchiano, A., Russo, G. & Croce
C.M. (1994). Characterization and localization of the TCL-1 oncogene
product. Cancer Res. 54, 6297-6301.
18. Stern, M.H., et al., & Kirsch, I.R. (1993) MTCP-1: a novel gene on the
human chromosome Xq28 translocated to the T cell receptor
alpha/delta locus in mature T cell proliferations. Oncogene 8, 2475-
2483.
19. Madani, A., et al., & Stern, M. H. (1996) Expression of p13MTCP1 is
restricted to T-cell proliferations with t(X;14) translocations. Blood 87,
1923-1927.
20. Soulier, J., Madani, A., Cacheux, V., Rosenzwajg, M., Sigaux, F. &
Stern, M.-H. (1994). The MTCP-1/c6.1B gene encodes for a
cytoplasmic 8 kD protein overexpressed in T cell leukemia bearing a
t(X;14) translocation. Oncogene 9, 3565-3570.
21. Thick, J., et al., & Taylor, A.M.R. (1996). Expression of either the TCL1
oncogene, or transcripts from its homologue MTCP1/c6.1B, in
leukaemic and non-leukaemic T cells from ataxia telangiectasia
patients. Oncogene 12, 379-386.
22. Yang, Y., et al., & Roumestand, C. (1998). Solution structure of the
recombinant human oncoprotein p13MTCP1. Biomol. NMR, in press.
23. Guignard, L., et al., & Roumestand, C. (1998). The preliminary solution
structure of human p13MTCP1, an oncogenic protein encoded by the
MTCP1 gene, using 2D homonuclear NMR. Chim. Phys., in press.
24. Murzin, A.G., Lesk, A.M. & Chotia, C. (1994). Principles determining
the structure of β-sheet barrels in proteins. A theoretical analysis. J.
Mol. Biol. 236, 1369-1381.
25. Murzin, A.G., Lesk, A.M. & Chotia, C. (1994). Principles determining
the structure of β-sheet barrels in proteins. The observed structures. J.
Mol. Biol. 236, 1382-1400.
26. Banaszak, L., Winter, N., Xu, Z., Berlohr, D.A., Cowan, S. & Jones, T.A.
(1994) Lipid binding protein: a family of fatty acid and retinoid
transport proteins. In Advances in Protein Chemistry. (Schumaker, V.,
ed.), vol 45, pp 89-149, Academic Press, San Diego, California.
27. Nicholls, A. (1992). GRASP: graphical representation and analysis of
surface properties, Columbia University, New York.
28. Otwinowski, Z. (1993). Oscillation data reduction program. In Data
Collection and Processing. Proceedings of the CCP4 Study
Weekend. (Sawyer, L., Isaacs, N. & Bailey, S., eds), pp. 56-62, SERC
Daresbury Laboratory, Warrington, UK.
29. Navaza, J. (1994). AMoRe: an automated package for molecular
replacement. Acta Cryst. D 50, 157-163.
30. Brünger, A. (1992). X-PLOR. Version 3.1. A system for X-ray
Crystallography and NMR. Yale University Press, New Haven, USA.
31. Roussel, A. & Cambillau, C. (1992). TURBO-FRODO, Biographics,
LCCMB, Marseille, France.
32. Brünger, A.T., Kuriyan, J. & Karplus, M. (1987). Crystallographic R-
factor refinement by molecular dynamics. Science 235, 458-460.
33. Brünger, A. (1992). The free-R value: a novel statistical quantity for
assessing the accuracy of crystal structures. Nature 355, 472-474.
34. Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J. (1993).
PROCHECK : a program to check the stereochemical quality of
protein structures. J. Appl. Cryst. 26, 283-291.
35. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed
and schematic plots of protein structures. J. Appl. Cryst. 24, 946-950.
36. Merrit, E. & Murphy, M. (1994). Raster 3D Version 2.0: a program for
realistic molecular graphics. Acta Cryst. D 50, 869-873.
Research Article  Structure of the oncoprotein p14TCL1 Hoh et al.    155
